Terminalia arjuna in cardiovascular diseases: Making the transition from traditional to modern medicine in India

Current Pharmaceutical Biotechnology

Volumn 11, Issue 8, 2010, Pages 855-860

  Maulik, S K ^a   Katiyar, C K ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Ayurvedic Research   (India)

Author keywords

Ayurveda; Cardiovascular disease; Clinical trial; Heart failure; Medicinal plants; Preconditioning; Terminalia arjuna

Indexed keywords

ALCOHOL; ARJUNGENIN; ARJUNIC ACID; ARJUNOGLUCOSIDE; ARJUNOLIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ELLAGIC ACID; FLAVONOID; GALLIC ACID; ISOSORBIDE MONONITRATE; LUTEOLIN; PLACEBO; PYCNOGENOL; TANNIN DERIVATIVE; TERMINALIA ARJUNA EXTRACT; UNCLASSIFIED DRUG; ANTIOXIDANT; CARDIOTONIC AGENT; PLANT EXTRACT; TRITERPENE; VASODILATOR AGENT;

ANTILIPEMIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; AYURVEDA; BARK; CARDIOVASCULAR DISEASE; CHRONOTROPISM; CLINICAL EFFECTIVENESS; DRUG ACTIVITY; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; INDIA; MITRAL VALVE REGURGITATION; NONHUMAN; OXIDATIVE STRESS; STABLE ANGINA PECTORIS; ANGINA PECTORIS; ANIMAL; CLINICAL TRIAL (TOPIC); HEART CONTRACTION; HEART RATE; PHYTOTHERAPY; REVIEW; TERMINALIA;

ANGINA; ANIMALIA; TERMINALIA ARJUNA;

ANGINA PECTORIS; ANIMALS; ANTIOXIDANTS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; FLAVONOIDS; HEART FAILURE; HEART RATE; HUMANS; INDIA; MEDICINE, AYURVEDIC; MYOCARDIAL CONTRACTION; PHYTOTHERAPY; PLANT BARK; PLANT EXTRACTS; TANNINS; TERMINALIA; TRITERPENES; VASODILATOR AGENTS;

EID: 79957941175     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920110793262051     Document Type: Article

References (48)

1. Alviano, D.S.; Alviano, C.S. Plant extracts: search for new alternatives to treat microbial diseases. Curr. Pharm. Biotechnol. 2009, 10 (1), 106-21.
2. Mishra, B.; Chunekar, K.C.; Bhava Prakasha Nighantu, Chaukhamaba Bharati Academy, Varanasi, 2002; pp. 523-524.
3. Ghoshal, L.M. Terminalia arjuna. Ph.D. thesis, Calcutta University, Calcutta, India, 1909.
4. Caius, J.S.; Mhaskar, K.S.; Isaacs, M. A comparative study of the dried barks of the commoner Indian species of genus Terminalia. Indian Med. Res. Memoirs, 1930, 16. 51-75.
5. sted.; UN Dhur & Sons: Calcutta, India, 1958, pp. 421-424.
6. Gupta, L.P.; Sen, S.P.; Udupa, K.N. Pharmacological studies on Terminalia arjuna. J. Res. Indian Med., Yoga and Homeopath., 1976, 11. 16-24.
7. Srivastava, R.D.; Dwivedi, S.; Sreenivasan, K.K.; Chandrashekhar, C.N. Cardiovascular effects of Terminalia species of plants. Indian Drugs. 1992, 29. 144-149.
8. Radhakrishnan, R.; Wadsworth, R.M.; Gray, A.I. Terminalia arjuna. an Ayurvedic cardiotonic, increases contractile force of rat isolated atria. Phytother. Res., 1993, 7, 266-268.
9. Vaidya, A.B. Terminalia arjuna is cardiovascular therapy. J. Assoc. Phys. India, 1994, 42, 281-282.
10. Nammi, S.; Gudavalli, R.; Babu, B.S.; Lodagala, D.S.; Boini, K.M. Possible mechanism of hypotension produced by 70% alcoholic extract of Terminalia arjuna (L.) in anaesthetised dogs. BMC Complement. Altern. Med., 2003, 3,5.
11. Takahashi, S.; Tanaka, H.; Hano, Y.; Ito, K.; Nomura, T.; Shigenobu, K. Hypotensive effects in rats of hydrophilic extract from Terminalia arjuna containing tannin-related compounds. Phytother. Res., 1997, 1. 424-427.
12. Takahashi, S.; Tanaka, H.; Hano, Y.; Ito, K.; Nomura, T.; Shigenobu, K. Hypotensive effects in rats of hydrophilic extract from Terminalia arjuna containing tannin-related compounds. Phytother. Res., 1997, 1. 424-427.
13. Singh, N.; Kapur, K.K.; Singh, S.P.; Shankar, K.; Sinha, J.N.; Kohli, R.P. Mechanism of cardiovascular action of Terminalia arjuna. Planta Med. 1982, 45. 102-104.
14. Kotur-Stevuljevic, J.; Memon, L.; Stefanovic, A.; Spasic, S.; Spasojevic-Kalimanovska, V.; Bogavac-Stanojevic, N.; Kalimanovska-Ostric, D.; Jeliś-Ivanovic, Z.; Zunic, G. Correlation of oxidative stress parameters and inflammatory markers in coronary artery disease patients. Clin. Biochem., 2007, 40(3-4), 181-187.
15. Gauthaman, K.; Maulik, M.; Kumari, R.; Manchanda, S.C.; Dinda, A.K.; Maulik, S.K. Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J. Ethnopharmacol., 2001, 75. 197-201.
16. Gauthaman, K.; Banerjee, S. K.; Dinda, A.K.; Ghosh, C.C.; Maulik, S.K. Terminalia arjuna (Roxb.) protects rabbit heart against ischemic-reperfusion injury: role of antioxidant enzymes and heat shock protein. J. Ethnopharmacol., 2005, 96 403-409.
17. Dancsó, B.; Spiró, Z.; Arslan, M.A.; Nguyen, M.T.; Papp, D.; Csermely, P.; Sćti, C. The heat shock connection of metabolic stress and dietary restriction. Curr. Pharm. Biotechnol., 2010, 7. 139-145.
18. Gray, C.C.; Amrani, M.; Yacoub, M.H. Heat stress proteins and myocardial protection: experimental model or potential clinical tool? Int. J. Biochem. Cell Biol., 1999, 31. 559-73.
19. Dwivedi, S.; Somani, P.N.; Chansouria, J.P.N.; Udupa, K.N. Cardioprotective effects of certain indigenous drugs in myocardial ischemia in rabbits. Indian J. Exp. Biol., 1988, 26. 969-975.
20. Sumitra, M.; Manikandan, P.; Kumar, D.A.; Arutselvan, N.; Balakrishna, K.; Manohar, B.M.; Puvanakrishnan, R. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol. Cell. Biochem., 2001, 224. 135-142.
21. Pawar, R.S.; Bhutani, K.K. Effect of oleanane triterpenoids from Terminalia arjuna-a cardioprotective drug on the process of respiratory oxyburst. Int. J. Phytomed. Phytopharmacol., 2005, 12, 391-393.
22. Karthikeyan, K.; Bai, B.R.; Gauthaman, K.; Sathish, K.S.; Devaraj, S.N. Cardioprotective effect of the alcoholic extract of Terminalia arjuna bark in an in vivo model of myocardial ischemic reperfusion injury. Life Sci., 2003, 73. 2727-2739.
23. Singh, G.; Singh, A.T.; Abraham, A.; Bhat, B.; Mukherjee, A.; Verma, R.; Agarwal, S.K.; Jha, S.; Mukherjee, R.; Burman, A.C. Protective effects of Terminalia arjuna against doxorubicin-induced cardiotoxicity. J. Ethnopharmacol., 2008, 117. 123-129.
24. Reddy, T.K.; Seshadri, P.; Reddy, K.K.; Jagetia, G.C.; Reddy, C.D. Effect of Terminalia arjuna extract on adriamycin-induced DNA damage. Phytother. Res., 2008, 22. 1188-1194.
25. Sinha, M.; Manna, P.; Sil, P.C. Terminalia arjuna protects mouse hearts against sodium fluoride-induced oxidative stress. J. Med. Food, 2008, 11. 733-740.
26. Kumar, S.; Enjamoori, R.; Jaiswal, A.; Ray, R.; Seth, S.; Maulik, S.K. Catecholamine-induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J. Pharm. Pharmacol., 2009, 61,1529-1536.
27. Tiwari, A.K.; Gode, J.D.; Dubey, G.P. Effect of Terminalia arjuna on lipid profiles of rabbit fed hypercholesterolemic diet. Pharm. Biol., 1990,28. 43-47.
28. Ram, A.; Lauria, P.; Gupta, R.; Kumar, R.; Sharma, V.S. Hypocholesterolemic effects of Terminalia arjuna tree bark. J. Ethnopharmacol., 1997, 55, 165-169.
29. Khanna, A.K.; Chander, C.; Kapoor, N.K. Terminalia arjuna: an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipidemic rats. Phytother. Res., 1996, 10. 663-666.
30. Shaila, H.P.; Udupa, S.L.; Udupa, A.L. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int. J. Cardiol., 1998, 67. 119-124.
31. Dwivedi, S.; Agarwal, M.P. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J. Assoc. Phys. India. 1994, 42(4), 287-289.
32. Bharani, A.; Ganguli, A.; Mathur, L.K.; Jamra, Y.; Raman, P.G. Efficacy of Terminalia arjuna in chronic stable angina: a doubleblind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate. Indian Heart J., 2002, 54(2),170-175.
33. Kumar, P.U.; Adhikari, P.; Pereira, P.; Bhat, P. Safety and efficacy of Hartone in stable angina pectoris--an open comparative trial. J. Assoc. Physicians India, 1999, 47. 685-689.
34. Dwivedi, S.; Aggarwal, A.; Agarwal, M.P.; Rajpal, S. Role of Terminalia arjuna in ischaemic mitral regurgitation. Int. J. Cardiol., 2005, 100. 507-508.
35. Bharani, A.; Ganguly, A.; Bhargava, K.D. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int. J. Cardiol., 1995, 49. 191-199.
36. Gupta, R.; Singhal, S.; Goyle, A.; Sharma, V.N. Antioxidant and hypocholesterolaemic effects of Terminalia arjuna tree-bark powder: a randomised placebo-controlled trial. J. Assoc. Physicians India, 2001, 49. 231-235.
37. Davignon, J.; Ganz, P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004, 109. 327-332.
38. Endemann, D.H.; Schiffrin, E.L. Endothelial dysfunction. J. Am. Soc. Nephrol., 2004, 15. 1983-1992.
39. Bharani, A.; Ahirwar, L.K.; Jain, N. Terminalia arjuna reverses impaired endothelial function in chronic smokers. Indian Heart J. 2004, 56(2),123-128.
40. Artham, S.M.; Lavie, C.J.; Milani, R.V.; Patel, D.A.; Verma, A.; Ventura, H.O. Clinical impact of left ventricular hypertrophy and implications for regression. Prog. Cardiovasc. Dis., 2009, 52(2),153-167.
41. Katz, A.M. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N. Engl. J. Med., 1990, 322. 100-110.
42. Prineas, R.J.; Rautaharju, P.M.; Grandits, G. MRFIT Research Group. Independent risk for cardiovascular disease predicted by modified continuous score ectrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the multiple riskfactor intervention trial, J. Electrocardiol., 2001, 34, 91-101.
43. Dwivedi, S.; Jauhari, R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J., 1997, 49. 507-510.
44. Wu, K.M.; Ghantous, H.; Birnkrant, D.B. Current regulatory toxicology perspectives on the development of herbal medicines to prescription drug products in the United States. Food Chem. Toxicol. 2008,46, 2606-2610
45. Ethical Guidelines for Biomedical Research on Human Subjects. Indian Council of Medical Research, New Delhi, India, 2000; pp. 51-52.
46. Chavez, M.L.; Jordan, M.A.; Chavez, P.I. Evidence-based drug--herbal interactions. Life Sci., 2006, 78. 2146-2157.
47. Tachjian, A.; Maria, V.; Jahangir, A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J. Am. Coll. Cardiol., 2010, 55. 515-525.
48. Buijsse, B.; Freskens, E. J.; Kok, F.J.; Kromhout, D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch. Intern. Med. 2006, 166. 411-417.